• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Improved recovery from vaginal surgery with dexamethasone

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
June 7, 2015
in Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Use of dexamethasone prior to vaginal prolapse surgery for pelvic organ prolapse was associated with less postoperative nausea and vomiting.

2. Patients who received dexamethasone were more likely to pass postoperative voiding trials compared to those on placebo.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Vaginal reconstruction for pelvic organ prolapse (POP) is a common, minimally invasive surgery that can vastly improve a woman’s quality of life. Further, it often requires only a one-day hospital stay and is associated with less morbidity than abdominal surgery. However, postoperative complications, like pain, nausea, and vomiting can complicate recovery and delay discharge. Dexamethasone is a widely used steroid that is inexpensive and has an excellent safety profile. Multiple studies demonstrated that dexamethasone is effective at improving postoperative nausea and pain in a range of surgeries, from cesarean sections, to laparoscopic gallbladder removal. It has never, however, been studied specifically in vaginal surgery for POP and can be associated with complications such as short-term immunosuppression and insulin resistance. In the present work, researchers assessed whether dexamethasone administration prior to general anesthesia was associated with improved recovery among women undergoing vaginal prolapse surgery.

Patients who received dexamethasone experienced an improved recovery as measured by post-operative nausea, emesis, and ability to void. Strengths of this double-blinded, randomized placebo-controlled trial included rigorous study design. Limitations included small sample size and exclusion of women with medical comorbidities (e.g. poorly controlled diabetes) which limits external validity, particularly since a plurality of women undergoing vaginal prolapse surgery are poor candidates for invasive surgery due to their comorbid conditions. Future studies might employ a larger patient population that includes women with medical morbidities to help answer this question.

Click to read the study in AJOG

Relevant Reading: Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section

RELATED REPORTS

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

Daily 12 mg dexamethasone not superior to 6 mg for severe COVID-19 infection

In-Depth [randomized controlled trial]: Women undergoing vaginal reconstructive surgery for POP were randomized to receive 8mg IV dexamethasone (n = 27) or placebo (n = 36) 60 minutes prior to surgery. The primary outcome was difference in Quality of Recovery (QoR-40) score 1 day postoperatively, where a lower difference indicates less symptomatology. Secondary outcomes included nausea and vomiting (PONV score) and Visual Analog Scales (VAS) for nausea/vomiting and pain.

Postoperatively, patients who received placebo were more likely to require antiemetics (11 vs 2, p = 0.029) and fail voiding trials (30 vs. 15; p = 0.037) compared to those randomized to dexamethasone. Those who received dexamethasone had a smaller decline in the QoR-40 “emotional state” domain (p = 0.04) and a lower VAS score for nausea/vomiting (p = 0.04). No adverse effects were noted among women randomized to dexamethasone.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: dexamethasonepelvic organ prolapse (POP)
Previous Post

Magnesium not associated with neuroprotection in preterm chorioamnionitis

Next Post

Nonlinear relationship between maternal hemoglobin and infant development

RelatedReports

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma
StudyGraphics

#VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma

May 19, 2022
#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma
StudyGraphics

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

December 18, 2021
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Emergency

Daily 12 mg dexamethasone not superior to 6 mg for severe COVID-19 infection

October 26, 2021
#VisualAbstract Indatuximab ravtansine in combination with immunomodulatory drugs shows objective and clinical response in patients with relapsed or refractory multiple myeloma
StudyGraphics

#VisualAbstract Indatuximab ravtansine in combination with immunomodulatory drugs shows objective and clinical response in patients with relapsed or refractory multiple myeloma

September 23, 2021
Next Post
Nonlinear relationship between maternal hemoglobin and infant development

Nonlinear relationship between maternal hemoglobin and infant development

Youth weapon violence linked to psychological consequences

Youth weapon violence linked to psychological consequences

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.